-
-
-
-
-
-
-
Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Arcutis projects ZORYVE sales of $455-470 million for 2026
-
-
-
-
-
-
-
Arcutis Announces Second Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million
-
-
-
-
-
-
-
Arcutis to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024
-
-
-
-
-
-
-
Jones Trading Downgrades Arcutis Biotherapeutics Inc. (ARQT) to Hold, 'Financial Risks'
-
-
-
-
-
-
-
Arcutis Biotherapeutics, Inc. (ARQT) Misses Q1 EPS by 3c
-
1,217,546 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

